Mednax, Inc (NYSE:MD) is reporting third quarter earnings results on Friday 6th November 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 0.40 per share.
For the full year, analysts predict revenues of $ 2446.75 million, while looking forward to income of $ 1.50 per share.
Previous Quarter Performance
Mednax, Inc unveiled income for the second quarter of $ 0.32 per share, from the revenue of $ 509.20 million. The quarterly earnings 64.04 percent compared with the same quarter last year. Street analysts expected Mednax, Inc to report income of $ 0.09 per share on revenue of $ 555.92 million for the second quarter. The bottom line results beat street analysts by $ 0.23 or 255.56 percent, at the same time, top line results fell short of analysts by $ 46.72 million or 8.4 percent.
Stock Performance
Shares of Mednax, Inc traded up $ 0.47 or 3.46 percent on Thursday, reaching $ 14.04 with volume of 562.50 thousand shares. Mednax, Inc has traded high as $ 14.19 and has cracked $ 13.67 on the downward trend
According to the previous trading day, closing price of $ 14.04, representing a 84.12 % increase from the 52 week low of $ 7.37 and a 52.65 % decrease over the 52 week high of $ 28.66.
The company has a market capital of $ 1.20 billion and is part of the Healthcare sector and Medical Care industry.
Recent Analyst recommendations
- On 19th October 2020, downgraded by Deutsche Bank to Sell from Hold rating, with $ 12.00 target price.
- On 6th October 2020, maintained by UBS Group at Sell rating, with $ 14.00 target price.
Conference Call
Mednax, Inc will be hosting a conference call at 9:00 AM eastern time on 6th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.mednax.com
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians.
